Idarucizumab

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Idarucizumab and local guidelines before prescribing.

Specific reversal agent

Mechanism

Monoclonal antibody fragment binding dabigatran.

Uses

Reversal of dabigatran in life-threatening bleeding or urgent surgery.

Dosing

Side effects

Headache, hypokalaemia, thrombosis risk after reversal.

Interactions

Specific to dabigatran.

Contraindications and cautions

None specific

Monitoring

Coagulation, bleeding

Pregnancy and breastfeeding

Use if life-threatening

Renal and hepatic impairment

No adjustment

Overdose and reversal

Not applicable

Special advice

Restart anticoagulation as soon as possible once bleeding controlled.

More from the textbook: uses, cautions and other points
Where it is discussed in the book